WA
AMED

Wealth Alliance’s Amedisys AMED Stock Holding History

Wealth Alliance’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,502
Closed -$229K – 491
2023
Q2 		$229K Buy
+2,502
New +$205K 0.03% 449
2022
Q2 		– Sell
-1,462
Closed -$252K – 444
2022
Q1 		$252K Buy
+1,462
New +$218K 0.05% 365
2021
Q3 		– Sell
-891
Closed -$218K – 430
2021
Q2 		$218K Sell
891
-45
-5% -$11.8K 0.05% 394
2021
Q1 		$248K Sell
936
-153
-14% -$43.1K 0.07% 334
2020
Q4 		$319K Buy
1,089
+4
+0.4% +$1.03K 0.09% 265
2020
Q3 		$257K Buy
1,085
+18
+2% +$4.09K 0.09% 267
2020
Q2 		$212K Buy
+1,067
New +$199K 0.08% 281

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Wealth Alliance's AMED Position: Q3 2023 in Review

Wealth Alliance sold out of Amedisys (AMED) in Q3 2023, closing a stake of 2,502 shares — an estimated $229K sold.

Wealth Alliance first reported a position in AMED in Q2 2020 and held it in 7 quarters. The position peaked at $319K in Q4 2020. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Wealth Alliance reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Wealth Alliance sold 2,502 Amedisys shares in Q3 2023, an estimated $229K.
  • Wealth Alliance first reported a position in Amedisys in Q2 2020 and held it in 7 quarters.
  • Wealth Alliance's Amedisys position peaked at $319K in Q4 2020.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Wealth Alliance's 13F filing for Q3 2023, filed 9 Nov 2023.